Histiocytic necrotizing lymphadenitis without granulocytic infiltration.

PubWeight™: 2.22‹?› | Rank: Top 2%

🔗 View Article (PMID 7112935)

Published in Virchows Arch A Pathol Anat Histol on January 01, 1982

Authors

S Pileri, M Kikuchi, D Helbron, K Lennert

Articles citing this

Necrotising lymphadenitis without granulocytic infiltration (Kikuchi's disease). J Clin Pathol (1985) 1.63

The plasmacytoid monocyte/interferon producing cells. Virchows Arch (2003) 1.13

Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature. Medicine (Baltimore) (2014) 1.03

Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy. Am J Pathol (2001) 1.02

Kikuchi's disease: an unusual presentation and a therapeutic challenge. Yale J Biol Med (2006) 0.95

Histiocytic necrotising lymphadenitis in systemic lupus erythematosus. Ann Rheum Dis (1992) 0.95

Bilateral pleural effusion and interstitial lung disease as unusual manifestations of Kikuchi-Fujimoto disease: case report and literature review. BMC Pulm Med (2010) 0.94

Kikuchi-Fugimoto disease (Cervical Subacute Necrotising Lymphadenitis): an important benign disease often masquerading as lymphoma. Ulster Med J (2009) 0.84

Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy. Eur Arch Otorhinolaryngol (2009) 0.84

Skin manifestations of Kikuchi-Fujimoto disease: case report and review. Eur J Pediatr (2004) 0.82

Histiocytic necrotizing lymphadenitis. Postgrad Med J (1988) 0.79

A rare case of multifocal lymphadenopathy in a young male. Oxf Med Case Reports (2014) 0.79

Characteristics of Kikuchi-Fujimoto disease in children compared with adults. Eur J Pediatr (2013) 0.77

Necrotizing lymphadenitis (NEL) is a systemic disease characterized by blastic transformation of CD8+ cells and apoptosis of CD4+ cells. Virchows Arch (2013) 0.77

Necrotising lymphadenitis without granulocytic infiltration (Kikuchi's disease) J Clin Pathol (1986) 0.75

Acute Tonsillitis With Concurrent Kikuchi's Disease as a Cause of Persistent Lymphadenopathy. Malays J Med Sci (2009) 0.75

Kikuchi's necrotizing lymphadenitis. West J Med (1985) 0.75

CT and US features of cervical lymphadenopathy due to kikuchi's disease. Indian J Otolaryngol Head Neck Surg (1997) 0.75

Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) with atypical encephalitis and painful testitis: a case report. BMC Neurol (2017) 0.75

Classification of haemolytic uraemic syndrome. J Clin Pathol (1986) 0.75

A Case of Recurrent Kikuchi-Fujimoto Disease. Jundishapur J Microbiol (2015) 0.75

Uncommon lymphadenopathies of immunopathogenesis can be misinterpreted as malignant diseases. Rheumatol Int (2006) 0.75

Necrotizing cervical lymphadenopathy: Kikuchi-Fujimoto disease in a young male. Wien Klin Wochenschr (2008) 0.75

[Diagnostic spectrum of reactive lymph node changes]. Pathologe (2008) 0.75

Articles by these authors

Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol (1993) 6.15

Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87

Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med (1995) 4.51

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood (2000) 3.99

Immunohistologic analysis of the organization of normal lymphoid tissue and non-Hodgkin's lymphomas. J Histochem Cytochem (1980) 3.47

Updated Kiel classification for lymphomas. Lancet (1988) 3.25

A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood (2000) 3.13

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A (1991) 2.82

Cloning and sequencing of Serratia protease gene. Nucleic Acids Res (1986) 2.72

Nonsense mutation of glucokinase gene in late-onset non-insulin-dependent diabetes mellitus. Lancet (1992) 2.71

CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67

Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med (1997) 2.59

ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41

Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40

Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer (1982) 2.39

ALK+ lymphoma: clinico-pathological findings and outcome. Blood (1999) 2.38

Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol (1985) 2.35

Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun (1997) 2.20

Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood (1994) 2.16

A novel avian hypothalamic peptide inhibiting gonadotropin release. Biochem Biophys Res Commun (2000) 2.16

Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia (1993) 2.11

Immunohistological analysis of human lymphoma: correlation of histological and immunological categories. Adv Cancer Res (1984) 2.03

Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03

Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr (2000) 1.95

Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95

Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology (1991) 1.94

Distribution of T cells bearing different forms of the T cell receptor gamma/delta in normal and pathological human tissues. J Immunol (1989) 1.89

Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med (1993) 1.84

PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol (1993) 1.81

DsbA-DsbB interaction through their active site cysteines. Evidence from an odd cysteine mutant of DsbA. J Biol Chem (1995) 1.76

BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood (1989) 1.76

Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology (1990) 1.74

Prediction of optimal atrioventricular delay in patients with implanted DDD pacemakers. Pacing Clin Electrophysiol (1999) 1.73

Splenic marginal zone lymphocytes and related cells in the lymph node: a morphologic and immunohistochemical study. Hum Pathol (1989) 1.69

Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol (2006) 1.68

Human herpesvirus-6 genomes in histiocytic necrotizing lymphadenitis (Kikuchi's disease) and other forms of lymphadenitis. Am J Clin Pathol (1993) 1.64

MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patients. Ann Oncol (2009) 1.62

Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol (1997) 1.59

Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol (1987) 1.59

Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia (2009) 1.56

Necrotizing lymphadenitis: possible acute toxoplasmic infection. Virchows Arch A Pathol Anat Histol (1977) 1.56

Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation (1997) 1.56

Molecular size and shape of beta-connectin, an elastic protein of striated muscle. J Biochem (1984) 1.53

Mast cells and mast cell neoplasia: a review. Histopathology (1979) 1.52

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51

Basic fibroblast growth factor stimulates repair of wounded hepatocyte monolayer: modulatory role of protein kinase A and extracellular matrix. J Lab Clin Med (1999) 1.47

Limb salvage using bypass to the perigeniculate arteries. Eur J Vasc Endovasc Surg (2011) 1.47

Rearrangement of the T-cell-receptor beta-chain gene in the diagnosis of lymphoproliferative disorders. Lancet (1985) 1.46

Sinus histiocytosis with massive lymphadenopathy: fifteen new cases. Cancer (1976) 1.46

Dermatofibroma: superficial fibrous proliferation with reactive histiocytes. A multiple immunostaining analysis. Cancer (1994) 1.44

Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases. Cancer (1994) 1.43

Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol (1993) 1.43

Acute 'bilineal-biphenotypic' leukaemia. Br J Haematol (1990) 1.42

Evolution of severe aplastic anemia to myelodysplasia with monosomy 7 following granulocyte colony-stimulating factor, erythropoietin and high-dose methylprednisolone combination therapy. Intern Med (1995) 1.41

Mast cell sarcoma of the larynx. J Clin Pathol (1986) 1.41

Detection of chromogranin A mRNA in small cell lung carcinoma using a new, highly sensitive in situ hybridization method with a non-radioisotope oligonucleotide probe. Cancer (1998) 1.40

Nonneoplastic and nonhyperplastic thymus in myasthenia gravis. An immunohistochemical study with double immunoenzymatic labeling of basement membrane and cellular components. Am J Clin Pathol (1990) 1.40

Overexpression of catalytic subunit p110alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J Biol Chem (1996) 1.39

Bone marrow findings in systemic mastocytosis. Hum Pathol (1985) 1.39

Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Am J Hematol (1996) 1.38

p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulin. J Biol Chem (1997) 1.37

Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes (1998) 1.37

Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood (1995) 1.37

Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia (2007) 1.36

S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gan (1982) 1.36

Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 1.35

Immunohistology and aetiology of histiocytic necrotizing lymphadenitis. Report of three instructive cases. Histopathology (1983) 1.35

Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet (1987) 1.34

Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients. Hum Pathol (2000) 1.34

Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer (2000) 1.34

The role of N-glycosylation of GLUT1 for glucose transport activity. J Biol Chem (1991) 1.32

14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. J Biol Chem (1997) 1.32

Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leuk Res (1989) 1.31

Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol (1997) 1.30

Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol (1996) 1.30

Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome). Virchows Arch A Pathol Anat Histol (1982) 1.30

Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food Chem Toxicol (2002) 1.30

Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol (1997) 1.29

Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology (1979) 1.28

Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol (1998) 1.28

Both PCE-1/RX and OTX/CRX interactions are necessary for photoreceptor-specific gene expression. J Biol Chem (2000) 1.28

MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia (2000) 1.27

Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Arch A Pathol Anat Histopathol (1989) 1.27

Complement receptor subtypes C3b and C3d in lymphatic tissue and follicular lymphoma. Br J Cancer (1978) 1.27

Malignant lymphomas of B-cell type. Lancet (1972) 1.27

[Interdigitating reticulum cell in the human lymph node. A specific cell of the thymus dependent region (author's transl)]. Virchows Arch B Cell Pathol (1974) 1.25

The LexA protein from Deinococcus radiodurans is not involved in RecA induction following gamma irradiation. J Bacteriol (2001) 1.24

p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity. J Biol Chem (2000) 1.24

Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann Oncol (1995) 1.24

Histological and immunohistological analysis of human lymphomas. Crit Rev Oncol Hematol (1989) 1.22

Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes (2000) 1.22

The roles of intracellular and extracellular Ca++ in glucose-stimulated biphasic insulin release by rat islets. J Clin Invest (1978) 1.21

A New Indole Alkaloid, 7 alpha-Hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand. Planta Med (1994) 1.20

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Ann Oncol (2009) 1.20

Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries. Biochemistry (1995) 1.20

Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology (2003) 1.19

A case of heterotopic pancreas in lymph node. Virchows Arch A Pathol Anat Histol (1978) 1.19

Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene. Br J Haematol (1999) 1.19